🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

Cross Country Healthcare, Inc. CCRN R2K

Healthcare · Medical Care Facilities · United States
https://www.crosscountry.com
Company Profile ↓
$13.24
+9.60% 1Y
Mkt Cap$427.74M
P/E-4.34
P/B1.32
52W High$14.23
52W Low$7.53
Book Value$10.01
EPS (TTM)$-3.05

Company Overview

Cross Country Healthcare, Inc. provides talent management services for healthcare clients in the United States. The company operates in two segments: Nurse and Allied Staffing, and Physician Staffing. The Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel nurse and allied professionals, per diem, and healthcare leaders within nursing, allied, human resources, and finance; vendor neutral and managed services programs; and education healthcare, caregiver services, and outsourcing services. This segment offers staffing solutions for registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and clinical and non-clinical professionals on long-term assignments, as well as workforce solutions, including MSP, VMS, RPO, project management, and other outsourcing and consultative services. It also provides retained search services for healthcare professionals, as well as contingent search and recruitment process outsourcing services. The company serves public and private acute care and non-acute care hospitals, government facilities, local and national healthcare plans, managed care providers, public and charter schools, outpatient clinics, ambulatory care facilities, correctional facilities, PACE programs, physician practice groups, and other healthcare providers. The Physician Staffing segment provides physicians in various specialties, certified registered nurse anesthetists, nurse practitioners, and physician assistants as independent contractors on temporary assignments. This segment serves various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations. The company was founded in 1986 and is headquartered in Boca Raton, Florida.

Why Investors Should Care

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

  • Dec 2025 Revenue of $1.05B (-21.6% YoY); net profit $-94.85M.
  • Trailing 12 Months Year-on-year growth — revenue -17.8%.
  • 5-Year Trend Long-term compounding — revenue CAGR 2.6%.

Growth & Price Performance

Compounded Sales Growth

5 Years:2.64%
1 Year:-17.80%

Stock Price Performance

1 Year:+9.60%
6 Months:+57.43%
3 Months:+35.52%
1 Month:+0.53%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bullish
52-Week Range 85% of range
$7.53 $14.23
Trend Signals
  • Price vs 50-DMAAbove
  • Price vs 200-DMAAbove
  • RSI (14)74.30 · Overbought
Price Performance
1M+0.53%
3M+35.52%
6M+57.43%
1Y+9.60%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Generates positive free cash flow.
  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

No notable concerns flagged.

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
-4.34
Industry PE
25.88
Forward P/E
47.29
PEG Ratio
12.60
Book Value
$10.01
Price to Book
1.32
P/S
0.43
EV/EBITDA
22.95
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
2.64%
Profit 5Y
-
Revenue (YoY)
-17.80%
Earnings (YoY)
-

Profitability & Returns

ROCE
-22.74%
ROE
-26.98%
ROA
-0.10%
Profit Margin
-9.84%
Op Margin
-0.81%
Gross Margin
20.21%
EPS (Latest Qtr)
$-0.14
EPS (TTM)
$-3.05

Balance Sheet & Liquidity

Debt/Equity
0.65
Quick Ratio
3.20
Current Ratio
3.29
Debt
$2.04M
Total Assets
$451.07M
Current Assets
-
Working Capital
-

Ownership

Promoter Holding
7.47%
Chg in Prom Hold
-0.00%
FII / Inst Holding
90.55%
Chg in FII Hold
-0.38%

Financial Snapshot

Enterprise Value
$427.74M
Total Revenue (TTM)
$1.00B
EBITDA
$14.11M
Free Cash Flow
$47.09M
Operating Cash Flow
$47.34M
Shares Outstanding
32.31M
Gross Margin
20.21%
Payout Ratio
0.00%

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP $P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 CCRN Cross Country Healthcare, Inc. R2K 13.24 -4.34 $427.74M 0.00% -22.74% -26.98% 2.64% -
2 LLY Eli Lilly and Company SPX 1,156.63 41.13 $1.03T 0.60% - 107.46% 7.20% 11.41%
3 JNJ Johnson & Johnson SPX 247.02 28.66 $594.63B 2.23% 14.88% 26.42% 2.43% 4.76%
4 ABBV AbbVie Inc. SPX 244.11 119.08 $431.29B 3.04% 10.47% -129.24% 1.75% -29.06%
5 UNH UnitedHealth Group Incorporated SPX 418.52 31.54 $380.08B 2.18% 9.74% 12.18% 10.40% 5.43%
6 MRK Merck & Co., Inc. SPX 123.61 34.82 $305.29B 2.82% - 18.94% 5.64% 10.01%
7 AZN AstraZeneca PLC NDX 168.37 26.10 $261.12B 1.87% 15.97% 23.48% 9.82% 45.96%
8 TMO Thermo Fisher Scientific Inc. SPX 535.29 29.40 $198.93B 0.35% 8.14% 13.52% 8.81% 12.95%
9 AMGN Amgen Inc. NDXSPX 358.32 24.92 $193.39B 2.80% 18.02% 101.32% 11.77% 5.58%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue -------210.29M204.57M200.72M200.91M195.17M202.76M209.20M215.10M210.06M216.78M193.97M215.61M329.24M331.83M374.90M640.68M788.73M753.56M636.10M628.22M622.71M540.70M442.29M414.04M379.17M339.77M315.12M309.94M293.41M274.07M250.05M236.76M241.06M
Gross Profit 54.85M58.21M57.63M53.27M56.53M60.48M58.30M53.75M53.69M51.56M50.56M48.25M51.59M51.01M53.16M49.60M50.73M48.00M54.39M71.47M72.59M83.79M147.15M174.79M170.41M143.54M138.94M139.42M123.14M97.36M90.49M77.30M70.81M64.16M61.99M58.66M56.00M50.93M47.98M-
Operating Income -17.02M9.33M-3.25M6.45M8.37M-4.25M4.34M2.65M--2.69M-15.10M119.00K--754.00K-13.69M-381.00K-20.99M15.90M26.45M-90.63M78.84M52.17M-43.80M35.19M20.30M-2.92M-19.21M2.85M--977.00K-5.86M-5.97M--4.16M
Net Income -17.24M14.07M-7.88M-2.01M4.85M6.72M27.95M1.64M1.54M-441.00K-19.69M-1.77M-51.67M-3.13M-1.14M-2.09M-14.15M-1.33M4.61M19.45M11.55M23.43M77.57M61.98M52.89M34.79M38.79M29.44M21.34M12.81M9.04M2.69M-16.05M2.56M-3.75M-490.00K-6.66M-4.77M-82.93M-4.27M
Diluted EPS -0.540.22-0.24-0.080.130.190.770.050.04-0.01-0.55-0.05-1.44-0.09-0.03-0.06-0.39-0.040.130.530.310.622.071.631.400.931.050.810.600.360.260.08-0.470.08-0.12-0.02-0.20-0.15-2.56-0.14

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue -------833.54M865.05M816.48M822.22M836.42M1.68B2.80B2.02B1.34B1.05B
Operating Income 17.70M-3.81M5.91M-24.52M-8.02M-10.47M20.57M6.18M11.75M-12.88M-15.71M-9.16M139.30M269.88M112.71M-16.86M-84.41M
Net Income 6.69M-2.77M4.10M-42.22M-51.97M-31.78M4.42M7.97M37.51M-16.95M-57.71M-12.96M132.00M185.98M72.63M-14.56M-94.85M
Diluted EPS 0.22-0.090.13-1.37-1.68-1.020.140.151.01-0.48-1.61-0.363.534.952.05-0.44-2.93

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets --343.66M347.94M305.92M248.25M325.13M365.60M388.38M467.69M427.00M382.37M356.97M732.81M949.59M681.06M589.25M448.95M
Total Equity 234.02M246.07M246.01M249.30M209.12M160.67M129.88M140.85M151.24M237.09M217.53M162.63M154.38M294.26M451.48M467.65M418.96M322.82M
Cash & Equivalents 10.17M6.86M10.96M10.65M10.46M8.05M5.00M2.45M20.63M25.54M16.02M-1.60M1.04M3.60M17.09M81.63M108.74M
Long Term Debt --------84.75M92.26M77.94M70.97M55.83M181.76M150.68M---
Total Liabilities --97.65M98.64M96.80M87.58M194.80M224.25M236.58M229.97M208.81M218.87M202.06M435.28M498.11M213.41M170.29M126.13M
Current Liabilities --35.25M51.09M72.59M44.91M67.00M86.05M97.09M94.59M85.39M85.47M93.42M199.77M279.13M156.08M120.40M77.76M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow -31.52M18.30M10.15M8.66M-4.07M18.23M30.14M45.51M21.00M5.54M27.20M-85.62M134.05M248.50M120.12M48.25M
Investing Cash Flow --16.20M-4.20M175.00K15.21M-45.45M-24.07M-9.78M-91.38M-6.68M-2.94M-4.62M-34.05M-43.87M-13.78M-8.71M-8.16M
Financing Cash Flow --11.19M-14.24M-10.58M-26.06M46.46M3.35M-2.16M50.76M-23.77M-17.60M-22.01M119.09M-87.60M-221.24M-46.85M-13.01M
Capital Expenditure -2.45M-2.39M-4.00M-2.22M-1.75M-4.57M-2.36M-6.52M-5.11M-4.60M-2.94M-4.62M-7.17M-8.79M-13.97M-8.71M-8.16M
Free Cash Flow -29.13M14.30M7.93M6.91M-8.64M15.87M23.62M40.40M16.40M2.60M22.59M-92.79M125.26M234.52M111.40M40.09M
Share Buybacks --2.23M374.00K00-005.00M00035.28M57.65M37.31M6.83M

Ratios (Annual)

Figures in %.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % -----------------
Operating Margin % -------0.7%1.4%-1.6%-1.9%-1.1%8.3%9.6%5.6%-1.3%-8.0%
Net Margin % -------1.0%4.3%-2.1%-7.0%-1.5%7.9%6.6%3.6%-1.1%-9.0%
ROE % 2.7%-1.1%1.6%-20.2%-32.3%-24.5%3.1%5.3%15.8%-7.8%-35.5%-8.4%44.9%41.2%15.5%-3.5%-29.4%
ROCE % --1.2%2.0%-10.5%-3.9%-4.1%7.4%2.1%3.1%-3.8%-5.3%-3.5%26.1%40.3%21.5%-3.6%-22.7%

Shareholding Pattern

Insiders
7.47%
Institutions
90.55%
Public Float
97.86%

Top Institutional Holders

#Holder% HeldSharesValue
1 Boston Partners 7.88% 2.55M $33.65M
2 Blackrock Inc. 7.76% 2.51M $33.14M
3 Dimensional Fund Advisors LP 4.98% 1.61M $21.28M
4 Vanguard Capital Management LLC 4.24% 1.37M $18.11M
5 Sio Capital Management, LLC 3.40% 1.10M $14.52M
6 Quinn Opportunity Partners, LLC 3.17% 1.03M $13.56M
7 Charles Schwab Investment Management, Inc. 2.95% 952.12K $12.59M
8 American Century Companies Inc 2.93% 948.13K $12.53M
9 Oddo BHF Asset Management SAS 2.91% 940.00K $12.43M
10 Dana Investment Advisors, Inc. 2.89% 933.22K $12.34M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for CCRN

Google News Wed, 15 Jul 2026

CCRN Stock Alert: Halper Sadeh LLC is Investigating Whether Cross Country Healthcare, Inc. is Obtaining a Fair Price for its Shareholders - Business Wire

<a href="https://news.google.com/rss/articles/CBMinAJBVV95cUxPRXEtMDUxNTVEaWJ2V3o1ZzNBNmZ4REhaTkJ5UE9iXzV5OTV1OEUtWHZvNjRwQ1BNQU5weTdJdkVzb3MtSWxhekhrWUFTZm10bjNFYnVhR2xUZllMa3ZEUGlodkJlUkVXLW9zbGRPb3k1Vk5YdGs2ck5aR3Vka25FWGJKNXM2Um8xYnVJMz…

Google News Fri, 10 Jul 2026

Cross Country Healthcare (NASDAQ: CCRN) CAO logs tax-related share withholding in Form 4 - Stock Titan

<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxPM2NFazNNUV91b081T0FHT2txZjk2TUx0dnNQVDdnTkdQeVFuaXFMa3d0OVFMSEFyb2Q1YWY0R0dmWEJ1czA0TDNhM3B3Ump3VmQ2a2lmMnVWa2hlREJlWTJmNUNrNDFMV0dwc3FYbVZZeU5ldDdzemt5bWJVYWdyVDYxTV9GR2ozZzM0X3…

Google News Mon, 13 Jul 2026

Behavioral Patterns of CCRN and Institutional Flows - Stock Traders Daily

<a href="https://news.google.com/rss/articles/CBMiygFBVV95cUxObkh3ZjEyZm9temc5UWpZMFBNdEtYczMzSW4taEpPQk40aXBXVGtGZnkxSXJyVzVjNnhYUko2eUUxUHRLQm9PX1o2N1ozMERLd2tXUXN5R3pkS0w4bHVkRzFVOWZ6TFg3dG80QXVDalJ5VG4wRjc0UHhnX3l6V1VjT0NiQXlpa0c5YVBIYT…

Google News Sat, 04 Apr 2026

How The Cross Country Healthcare (CCRN) Story Is Shifting With Margin Goals And Travel Nurse Demand - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxNaTBEMXZUSE9IX0ZCcnJac3dGU1VfU01Dc00tVTY2ZDZ0UWMycWN0SmNLVmwtVmN5Y2RXbWJndXJFelR2aXNLMjVDQWh4MXNLcmcwNnFZYm84UlY5R1BxbnpUMTkxTGl5Y3NzUFVFa1BrUXBmZkN0U01RZDgybmhwWTJtV2daT0VKZzFNMC…

Google News Fri, 26 Jun 2026

Cross Country Healthcare, Inc. Actuals & Estimates (NASDAQ:CCRN) - TradingView

<a href="https://news.google.com/rss/articles/CBMihgFBVV95cUxOMjEzY0NCaVRNbzhpcHhZTTRwSEd3cjJZNElmLXFTdGFJVFl0c1FtdUhveTVzTktKNFpJNDB3YkVNd0xvZHJvQllWTWcxZUtnNU5xQzZBaTc4aVNYc1NCT0pQWjZUVWhjX2VVX2hncVozNVg4Si15d2xKdGU0U09WYWdzUnFIdw?oc=5" t…

Google News Wed, 04 Mar 2026

Cross Country Healthcare Inc. (CCRN) Stock Falls on Q4 2025 Earnings - Quiver Quantitative

<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxPbUpBQm9YeFR5bjlNYWY4YmFiWGNaTk1yOVlqWUdhWk51RE96ZTd0dWFfc3BfTUwzc0hPOGpQdkNlbG5CNk5oMkh1NWhMaEhxSkc0ZzU5bUdkNTRrS3A3UW1hbjR0M0ZsMmpCc204LUg5SUNhTHNHOGNYVjF6MGxmSUJsODV2eUpSYklxcz…

CCRN — Frequently Asked Questions

What is the current share price of Cross Country Healthcare, Inc. (CCRN)?

As of 2026-07-15 16:51 PDT, Cross Country Healthcare, Inc. (CCRN) trades at $13.24 on NasdaqGS. Its 52-week range is $7.53 to $14.23.

What is the market capitalisation of CCRN?

Cross Country Healthcare, Inc. (CCRN) has a market capitalisation of $427.74M on NasdaqGS.

What is the P/E ratio of CCRN?

CCRN trades at a trailing price-to-earnings (P/E) ratio of -4.34. The industry average P/E is 25.88. Its price-to-book (P/B) ratio is 1.32.

What is the return on equity (ROE) of CCRN?

CCRN has a return on equity (ROE) of -26.98%. Its return on capital employed (ROCE) is -22.74%.

Is CCRN a good stock to buy?

This page provides a data-driven analysis of Cross Country Healthcare, Inc. (CCRN), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space